Lincoln National Corp Novartis Ag Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$95.27 - $108.47 $49,921 - $56,838	-524 Reduced 4.84%	10,302 $996,000
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $170,330 - $187,442	1,846 Added 20.56%	10,826 $1.09 Million
Q3 2023 Nov 03, 2023	BUY	$94.73 - $105.13 $18,567 - $20,605	196 Added 2.23%	8,980 $914,000
Q2 2023 Aug 04, 2023	BUY	$92.52 - $104.91 $63,746 - $72,282	689 Added 8.51%	8,784 $886,000
Q1 2023 May 01, 2023	SELL	$80.03 - $92.81 $3,201 - $3,712	-40 Reduced 0.49%	8,095 $744,000
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $90,131 - $110,376	1,193 Added 17.19%	8,135 $738,000
Q3 2022 Nov 03, 2022	BUY	$74.61 - $87.26 $17,234 - $20,157	231 Added 3.44%	6,942 $528,000
Q2 2022 Aug 02, 2022	BUY	$80.52 - $93.75 $88,088 - $102,562	1,094 Added 19.48%	6,711 $568,000
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $26,195 - $29,632	-327 Reduced 5.5%	5,617 $493,000
Q4 2021 Jan 26, 2022	SELL	$79.7 - $88.13 $1,354 - $1,498	-17 Reduced 0.29%	5,944 $520,000
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $139,353 - $162,118	-1,704 Reduced 22.23%	5,961 $488,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $61,798 - $68,258	725 Added 10.45%	7,665 $699,000
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $19,121 - $22,549	229 Added 3.41%	6,940 $593,000
Q4 2020 Feb 05, 2021	SELL	$78.07 - $94.43 $12,491 - $15,108	-160 Reduced 2.33%	6,711 $634,000
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $119,924 - $132,860	-1,460 Reduced 17.52%	6,871 $597,000
Q2 2020 Jul 31, 2020	BUY	$80.93 - $91.1 $6,069 - $6,832	75 Added 0.91%	8,331 $727,000
Q1 2020 Apr 24, 2020	SELL	$70.67 - $99.01 $37,949 - $53,168	-537 Reduced 6.11%	8,256 $681,000
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $351,992 - $397,979	4,173 Added 90.32%	8,793 $832,000
Q3 2019 Nov 06, 2019	BUY	$85.54 - $94.26 $185,621 - $204,544	2,170 Added 88.57%	4,620 $401,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $3,543 - $4,361	-47 Reduced 1.88%	2,450 $224,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $12,503 - $14,300	-166 Reduced 6.23%	2,497 $240,000
Q4 2018 Feb 08, 2019	BUY	$73.66 - $82.02 $6,997 - $7,791	95 Added 3.7%	2,663 $228,000
Q3 2018 Nov 06, 2018	SELL	$66.94 - $77.43 $10,576 - $12,233	-158 Reduced 5.8%	2,568 $221,000
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $57,704 - $65,217	-889 Reduced 24.59%	2,726 $206,000
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $256,712 - $306,895	-3,647 Reduced 50.22%	3,615 $292,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $279,049 - $299,535	3,858 Added 113.34%	7,262 $610,000
Q3 2017 Oct 31, 2017	BUY	$74.14 - $77.27 $26,912 - $28,049	363 Added 11.94%	3,404 $292,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,041	3,041 $253,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account